VBL THERAPEUTICS

VBL Therapeutics is an innovative and diversified, clinical stage biotechnology company committed to the discovery, development and commercialization of novel treatments for cancer and immune-inflammatory diseases. Currently available therapies are limited in their ability to adequately treat these serious and oftentimes life-threatening diseases. VBL was founded to create new treatment options that address these unmet medical needs. VBL’s clinical pipeline is based on two distinct, proprietary platform technologies that leverage the body’s natural physiologic and genetic regulatory elements. To date, VBL has developed two programs based on these platforms – an oncology program and an anti-inflammatory program.

#SimilarOrganizations #People #Financial #Event #Website #More

VBL THERAPEUTICS

Social Links:

Facebook

Twitter

Industry:

Biotechnology Genetics Health Care Medical

Founded:

2000-01-01

Address:

Or Yehuda, Tel Aviv, Israel

Country:

Israel

Website Url:

http://www.vblrx.com

Total Employee:

11+

Status:

Active

Contact:

+97236346450

Email Addresses:

[email protected]

Total Funding:

58.72 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt Domain Not Resolving Microsoft Exchange Online Amazon Office 365 Mail IPv6

Similar Organizations

arbutus-biopharma-logo

Current Advisors List

dan-j-gelvan_image

Dan J. Gelvan Member of Board of Directors @ VBL THERAPEUTICS
Board_member

Current Employees Featured

sam-backenroth_image

Sam Backenroth
Sam Backenroth Chief Financial Officer @ VBL THERAPEUTICS
Chief Financial Officer
2021-10-01

dror-harats_image

Dror Harats
Dror Harats CEO @ VBL THERAPEUTICS
CEO

not_available_image

Jide Zeitlin
Jide Zeitlin COO @ VBL THERAPEUTICS
COO

amos-ron_image

Amos Ron
Amos Ron Chief Financial Officer @ VBL THERAPEUTICS
Chief Financial Officer

yael-cohen_image

Yael Cohen
Yael Cohen VP Clinical Development @ VBL THERAPEUTICS
VP Clinical Development

Founder

dror-harats_image

Dror Harats

Stock Details

Company's stock symbol is NASDAQ:VBLT

Investors List

european-innovation-council_image

Key Employee Changes

Date	New article
2021-10-05	VBL Therapeutics Announces Appointment of Sam Backenroth as Chief Financial Officer and Establishes Operations in the United States

Official Site Inspections

http://www.vblrx.com Semrush global rank: 2.56 M Semrush visits lastest month: 6.87 K

Host Informations
Whois Informations

Loading ...